ASLN - ASLAN Pharmaceuticals Limited

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Show:
Income statement
Balance sheet
Cash flow

Income statement

Annual
Currency in TWD. All numbers in thousands
Revenue31/12/201731/12/201631/12/201531/12/2014
Total revenue-373,018--
Cost of revenue-4,038--
Gross profit-368,980--
Operating expenses
Research development908,801425,296210,471285,252
Selling general and administrative276,831224,721223,690178,568
Non-recurring----
Others----
Total operating expenses1,185,632654,055434,161463,820
Operating income or loss-1,185,632-281,037-434,161-463,820
Income from continuing operations
Total other income/expenses net-22,788-11,288-16,466-3,140
Earnings before interest and taxes-1,185,632-281,037-434,161-463,820
Interest expense-12,623-16,932-33,376-18,732
Income before tax-1,208,420-292,325-450,627-466,960
Income tax expense----
Minority interest----
Net income from continuing ops-1,208,420-292,325-450,627-466,960
Non-recurring events
Discontinued operations----
Extraordinary items----
Effect of accounting changes----
Other items----
Net income
Net income-1,208,420-292,325-450,627-466,960
Preferred stock and other adjustments----
Net income applicable to common shares-1,208,420-292,325-450,627-466,960